Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of MethylGene patents

Patents where

Current Assignee

Name

‌

MethylGene

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7868205 Inhibitors of histone deacetylase	Patent 7868205 was granted and assigned to MethylGene on January, 2011 by the United States Patent and Trademark Office.		‌ MethylGene	United States Patent and Trademark Office	7868205	January 11, 2011
‌ US Patent 7253204 Inhibitors of histone deacetylase	Patent 7253204 was granted and assigned to MethylGene on August, 2007 by the United States Patent and Trademark Office.		‌ MethylGene	United States Patent and Trademark Office	7253204	August 7, 2007
‌ US Patent 7514556 Inhibitors of β-lactamase	Patent 7514556 was granted and assigned to MethylGene on April, 2009 by the United States Patent and Trademark Office.		‌ MethylGene	United States Patent and Trademark Office	7514556	April 7, 2009
‌ US Patent 7282608 Inhibitors of histone deacetylase	Patent 7282608 was granted and assigned to MethylGene on October, 2007 by the United States Patent and Trademark Office.		‌ MethylGene	United States Patent and Trademark Office	7282608	October 16, 2007
‌ US Patent 8088805 Inhibitors of histone deacetylase	Patent 8088805 was granted and assigned to MethylGene on January, 2012 by the United States Patent and Trademark Office.		‌ MethylGene	United States Patent and Trademark Office	8088805	January 3, 2012
‌ US Patent 6897220 Inhibitors of histone deacetylase	Patent 6897220 was granted and assigned to MethylGene on May, 2005 by the United States Patent and Trademark Office.		‌ MethylGene	United States Patent and Trademark Office	6897220	May 24, 2005
‌ US Patent 8093264 Fused heterocycles as inhibitors of VEGF receptor and HGF receptor signaling	Patent 8093264 was granted and assigned to MethylGene on January, 2012 by the United States Patent and Trademark Office.		‌ MethylGene	United States Patent and Trademark Office	8093264	January 10, 2012
‌ US Patent 7868204 Inhibitors of histone deacetylase	Patent 7868204 was granted and assigned to MethylGene on January, 2011 by the United States Patent and Trademark Office.		‌ MethylGene	United States Patent and Trademark Office	7868204	January 11, 2011
‌ US Patent 8470850 Inhibitors of VEGF receptor and HGF receptor signalling	Patent 8470850 was granted and assigned to MethylGene on June, 2013 by the United States Patent and Trademark Office.		‌ MethylGene	United States Patent and Trademark Office	8470850	June 25, 2013
‌ US Patent 9018378 Processes and intermediates for preparing fused heterocyclic kinase inhibitors	Patent 9018378 was granted and assigned to MethylGene on April, 2015 by the United States Patent and Trademark Office.	‌ MethylGene	‌ MethylGene	United States Patent and Trademark Office	9018378	April 28, 2015
‌ US Patent 8404846 Inhibitors of protein tyrosine kinase activity	Patent 8404846 was granted and assigned to MethylGene on March, 2013 by the United States Patent and Trademark Office.		‌ MethylGene	United States Patent and Trademark Office	8404846	March 26, 2013
‌ US Patent 8389541 Inhibitors of protein tyrosine kinase activity	Patent 8389541 was granted and assigned to MethylGene on March, 2013 by the United States Patent and Trademark Office.		‌ MethylGene	United States Patent and Trademark Office	8389541	March 5, 2013
‌ US Patent 8759400 Histone deacetylase inhibitors for enhancing activity of antifungal agents	Patent 8759400 was granted and assigned to MethylGene on June, 2014 by the United States Patent and Trademark Office.		‌ MethylGene	United States Patent and Trademark Office	8759400	June 24, 2014
‌ US Patent 8354445 Inhibitors of histone deacetylase	Patent 8354445 was granted and assigned to MethylGene on January, 2013 by the United States Patent and Trademark Office.		‌ MethylGene	United States Patent and Trademark Office	8354445	January 15, 2013
‌ US Patent 8455484 Selected inhibitors of protein tyrosine kinase activity	Patent 8455484 was granted and assigned to MethylGene on June, 2013 by the United States Patent and Trademark Office.		‌ MethylGene	United States Patent and Trademark Office	8455484	June 4, 2013
‌ US Patent 8598168 Inhibitors of histone deacetylase	Patent 8598168 was granted and assigned to MethylGene on December, 2013 by the United States Patent and Trademark Office.		‌ MethylGene	United States Patent and Trademark Office	8598168	December 3, 2013
‌ US Patent RE43343 Inhibitors of histone deacetylase	Patent RE43343 was granted and assigned to MethylGene on May, 2012 by the United States Patent and Trademark Office.		‌ MethylGene	United States Patent and Trademark Office	RE43343	May 1, 2012
‌ US Patent 8338437 Amines as small molecule inhibitors	Patent 8338437 was granted and assigned to MethylGene on December, 2012 by the United States Patent and Trademark Office.		‌ MethylGene	United States Patent and Trademark Office	8338437	December 25, 2012
‌ US Patent 8846927 Inhibitors of protein tyrosine kinase activity	Patent 8846927 was granted and assigned to MethylGene on September, 2014 by the United States Patent and Trademark Office.	‌ MethylGene	‌ MethylGene	United States Patent and Trademark Office	8846927	September 30, 2014
‌ US Patent 9096565 Inhibitors of histone deacetylase	Patent 9096565 was granted and assigned to MethylGene on August, 2015 by the United States Patent and Trademark Office.		‌ MethylGene	United States Patent and Trademark Office	9096565	August 4, 2015
‌ US Patent 7772247 Substituted thieno[3,2-d]pyridines as inhibitors of the VEGF receptor and HGF receptor	Patent 7772247 was granted and assigned to MethylGene on August, 2010 by the United States Patent and Trademark Office.		‌ MethylGene	United States Patent and Trademark Office	7772247	August 10, 2010
‌ US Patent 8759522 Inhibitors of protein tyrosine kinase activity	Patent 8759522 was granted and assigned to MethylGene on June, 2014 by the United States Patent and Trademark Office.		‌ MethylGene	United States Patent and Trademark Office	8759522	June 24, 2014
‌ US Patent 8673911 Inhibitors of histone deacetylase	Patent 8673911 was granted and assigned to MethylGene on March, 2014 by the United States Patent and Trademark Office.		‌ MethylGene	United States Patent and Trademark Office	8673911	March 18, 2014
‌ US Patent 8729268 Inhibitors of protein tyrosine kinase activity	Patent 8729268 was granted and assigned to MethylGene on May, 2014 by the United States Patent and Trademark Office.		‌ MethylGene	United States Patent and Trademark Office	8729268	May 20, 2014
‌ US Patent 8907091 Processes and intermediates for preparing fused heterocyclic kinase inhibitors	Patent 8907091 was granted and assigned to MethylGene on December, 2014 by the United States Patent and Trademark Office.		‌ MethylGene	United States Patent and Trademark Office	8907091	December 9, 2014

Results per page:

36 results

0 selected

36 results

0 selected